Inherited burden for disease predisposition in diverse populations

Barış Kayaalp1, Meltem Ece Kars2, Yuval Itan2,3,4

  • 1Department of Molecular Biology and Genetics, Faculty of Science, Bilkent University, Ankara, Türkiye.

NPJ Genomic Medicine
|February 18, 2026
PubMed
Summary

Individuals carry an average of 4.70 pathogenic or likely pathogenic genetic variants, with 1 in 11 having actionable genotypes. This genetic data aids personalized medicine and preventive health strategies.

Related Concept Videos

Pedigree Analysis01:35

Pedigree Analysis

Overview
89.9K
Genetic Lingo01:11

Genetic Lingo

Overview
115.6K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.2K
Probability Laws01:49

Probability Laws

Overview
44.6K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.8K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
18